RHHBY
Price:
$40.49
Market Cap:
$222.09B
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2003-08-20
Stock Exchange
PNK
Ticker
RHHBY
According to Roche Holding AG’s latest financial reports and current stock price. The company's current ROE is 54.68%. This represents a change of 299.53% compared to the average of 13.69% of the last 4 quarters.
The mean historical ROE of Roche Holding AG over the last ten years is 42.16%. The current 54.68% ROE has changed 29.69% with respect to the historical average. Over the past ten years (40 quarters), RHHBY's ROE was at its highest in in the June 2022 quarter at 33.86%. The ROE was at its lowest in in the September 2018 quarter at 5.78%.
Average
42.16%
Median
40.63%
Minimum
32.65%
Maximum
56.88%
Discovering the peaks and valleys of Roche Holding AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 44.61%
Maximum Annual ROE = 56.88%
Minimum Annual Increase = -21.99%
Minimum Annual ROE = 32.65%
Year | ROE | Change |
---|---|---|
2023 | 39.22% | -11.61% |
2022 | 44.37% | -21.99% |
2021 | 56.88% | 44.61% |
2020 | 39.34% | -4.56% |
2019 | 41.22% | 8.43% |
2018 | 38.01% | 16.43% |
2017 | 32.65% | -18.47% |
2016 | 40.05% | -5.20% |
2015 | 42.25% | -11.33% |
2014 | 47.65% | -17.66% |
The current ROE of Roche Holding AG (RHHBY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
46.83%
5-year avg
44.21%
10-year avg
42.16%
Roche Holding AG’s ROE is less than Sanofi (10.71%), less than AstraZeneca PLC (16.80%), less than GSK plc (29.50%), less than Merck & Co., Inc. (33.75%), less than Novartis AG (38.92%), greater than Bristol-Myers Squibb Company (-28.46%), less than Gilead Sciences, Inc. (5.21%),
Company | ROE | Market cap |
---|---|---|
10.71% | $144.70B | |
16.80% | $257.50B | |
29.50% | $89.06B | |
33.75% | $298.70B | |
38.92% | $228.22B | |
-28.46% | $98.73B | |
5.21% | $98.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Roche Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Roche Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Roche Holding AG's ROE?
How is the ROE calculated for Roche Holding AG (RHHBY)?
What is the highest ROE for Roche Holding AG (RHHBY)?
What is the 3-year average ROE for Roche Holding AG (RHHBY)?
What is the 5-year average ROE for Roche Holding AG (RHHBY)?
How does the current ROE for Roche Holding AG (RHHBY) compare to its historical average?